Jungsub Choi

Title: Jungsub Choi: Innovator in Pharmaceutical Formulations

Introduction

Jungsub Choi is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the stability and efficacy of treatments for various diseases. With a total of 2 patents, his work is recognized for its potential impact on medical therapies.

Latest Patents

Jungsub Choi's latest patents include a pharmaceutical formulation comprising an anti-epidermal growth factor receptor (EGFR) antibody. This formulation is characterized by low turbidity and stability, making it suitable for treating disorders such as cancer. Another significant patent is for a novel crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate. This compound exhibits excellent stability in high-temperature and humidity environments, which is beneficial for preventing or treating diseases like thrombosis and myocardial infarction.

Career Highlights

Throughout his career, Jungsub Choi has worked with reputable companies such as the Green Cross Corporation and Legochem Biosciences, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Jungsub Choi has collaborated with notable colleagues, including Yoo Hoon Kim and Yong Woon Choi. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Jungsub Choi's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patents reflect a dedication to improving treatment options for serious health conditions.